CYP4X1 Inhibition by Flavonoid CH625 Normalizes Glioma Vasculature through Reprogramming TAMs via CB2 and EGFR-STAT3 Axis [Drug Discovery and Translational Medicine]

Wang, C., Li, Y., Chen, H., Huang, K., Liu, X., Qiu, M., Liu, Y., Yang, Y., Yang, J.
The American Society for Pharmacology and Experimental Therapeutics
Published 2018